Publications by authors named "Hitomi Jo"

Claim this Profile
T
The inciting factor for bradycardia in COVID-19 patients: a potential harm of steroid treatment.
Misa Ogiwara, Hiroaki Ihara, Yuki Muto, Manami Haba, Hiroki Nakazawa, Hitomi Jo

J Thorac Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC.
Hitomi Jo, Tatsuya Yoshida, Shigehiro Yagishita, Mayu Ohuchi, Yuji Matsumoto

JTO Clin Res Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients.
Mayu Ohuchi, Shigehiro Yagishita, Hitomi Jo, Kazumasa Akagi, Ryoko Inaba Higashiyama

Lung Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between body mass index and efficacy of anti-PD-1 inhibitor in patients with non-small cell lung cancer.
Akiko Tateishi, Hidehito Horinouchi, Tatsuya Yoshida, Ken Masuda, Hitomi Jo

Respir Investig· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Hitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi, Shigehiro Yagishita, Yuji Matsumoto

Cancer Immunol Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations.
Hitomi Jo, Shigehiro Yagishita, Yoshiharu Hayashi, Shoraku Ryu, Mikiko Suzuki

Mol Cancer Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients.
Yukiko Shimoda, Tatsuya Yoshida, Masayuki Shirasawa, Takaaki Mizuno, Hitomi Jo

Anticancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of pembrolizumab therapy in advanced-NSCLC patients with poor performance status (≥3) and high PD-L1 expression (TPS ≥50%): A case series.
Ryoko Inaba-Higashiyama, Tatsuya Yoshida, Hitomi Jo, Masayuki Shirasawa, Noriko Motoi

Thorac Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patient.
Munehiro Ito, Shintaro Kanda, Tatsuya Yoshida, Yusuke Okuma, Hitomi Jo

Lung Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.
Ryota Kanemaru, Yoshiteru Morio, Hidenori Takekawa, Hitomi Jo, Fumiko Kasuga

Respir Investig· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loxoprofen-induced interstitial pneumonia: a case report.
Motoyasu Kato, Shinichi Sasaki, Yasuhito Sekimoto, Naoko Arano, Hitomi Jo

J Med Case Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune pulmonary alveolar proteinosis with primary lung cancer in a patient of very advanced years.
Shin-ichiro Iwakami, Mitsuhiro Fujii, Takeo Tsutsumi, Yasuhito Sekimoto, Hitomi Jo

Geriatr Gerontol Int· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis